Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCF1 pseudogene 10 (FCF1P10) is a processed or duplicated pseudogene derived from the FCF1 gene, which encodes a protein involved in ribosomal small subunit biogenesis[3]. Pseudogenes such as FCF1P10 generally contain disabling mutations and do not produce functional proteins. While some pseudogenes can regulate their parental genes or participate in complex regulatory networks at the RNA level, there is no published evidence for a specific biological function or disease association of FCF1P10[2][4]. Consequently, FCF1P10 is not considered a therapeutic target, receptor, or enzyme. There are no known drugs interacting with this pseudogene, nor are there recognized uses as a biomarker or special therapeutic safety concerns. In summary, FCF1P10 is best classified as a non-functional gene remnant (pseudogene) related to ribosomal biogenesis, lacking evidence for direct biological, therapeutic, or pathological roles[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCF1 small subunit processome component homolog pseudogene 10 (FCF1P10).